Baculoviral IAP Repeat-Containing Protein 7 (BIRC7) Antibody

260€ (50 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Baculoviral IAP Repeat-Containing Protein 7 (BIRC7) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx456792
tested applications
ELISA, WB, IHC
Description
Baculoviral IAP Repeat-Containing Protein 7 (BIRC7) Antibody is a Rabbit polyclonal antibody for the detection of Human Baculoviral IAP Repeat-Containing Protein 7 (BIRC7).
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Primary Antibodies |
Immunogen Target | Baculoviral IAP Repeat-Containing Protein 7 (BIRC7) |
Host | Rabbit |
Reactivity | Human |
Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Polyclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Size 1 | 50 µg |
Size 2 | 100 µg |
Form | Liquid |
Tested Applications | ELISA, WB, IHC |
Buffer | 0.01 M PBS, pH 7.4, 50% glycerol, 0.05% Proclin-300. |
Availability | Shipped within 5-12 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
UniProt ID | Q96CA5 |
Gene ID | 79444 |
NCBI Accession | NP_071444.1 |
Background | Antibody anti-BIRC7 |
Status | RUO |
Descripción
Related Products

Human BIRC7 (Baculoviral IAP repeat-containing protein 7) ELISA Kit
Ver Producto
Recombinant Human BIRC7
Ver Producto
Baculoviral IAP Repeat Containing Protein 7 (BIRC7) Antibody
BIRC7 Antibody is a Rabbit Polyclonal antibody against BIRC7. This gene encodes a member of the inhibitor of apoptosis protein (IAP) family, and contains a single copy of a baculovirus IAP repeat (BIR) as well as a RING-type zinc finger domain. The BIR domain is essential for inhibitory activity and interacts with caspases, while the RING finger domain sometimes enhances antiapoptotic activity but does not inhibit apoptosis alone. Elevated levels of the encoded protein may be associated with cancer progression and play a role in chemotherapy sensitivity. Alternative splicing results in multiple transcript variants.
Ver Producto